Latest period
$1.80B
YoY change
+33.4%
5Y CAGR
+6.8%
Peak year (2022)
$1.47B
Latest annual
$1.45B
Cash on Hand history chart for Viatris (VTRS) from 2003 to 2025
Latest: $1.45B
Cash on Hand growth chart for Viatris (VTRS) from 2003 to 2025
Latest: +33.4%
Cash on Hand history table for Viatris (VTRS) from 2003 to 2025
| 2025 | $1.45B | +33.4% | +$364.50M | ||
| 2024 | $1.09B | -8.0% | −$94.50M | ||
| 2023 | $1.18B | -19.6% | −$288.10M | ||
| 2022 | $1.47B | +57.5% | +$537.50M | ||
| 2021 | $935.00M | -10.8% | −$112.90M | ||
| 2020 | $1.05B | +79.2% | +$463.20M | ||
| 2019 | $584.70M | +30.2% | +$135.50M | ||
| 2018 | $449.20M | +7.2% | +$30.30M | ||
| 2017 | $418.90M | -63.2% | −$719.50M | ||
| 2016 | $1.14B | -15.6% | −$210.70M | ||
| 2015 | $1.35B | +374.9% | +$1.06B | ||
| 2014 | $284.10M | -30.5% | −$124.50M | ||
| 2013 | $408.60M | +16.8% | +$58.63M | ||
| 2012 | $349.97M | -15.7% | −$65.05M | ||
| 2011 | $415.02M | -42.0% | −$300.09M | ||
| 2010 | $715.11M | +56.8% | +$259.07M | ||
| 2009 | $456.04M | -28.7% | −$183.68M | ||
| 2008 | $639.72M | +11.1% | +$64.15M | ||
| 2007 | $575.56M | — | — | ||
| 2005 | $518.13M | -35.9% | −$289.95M | ||
| 2004 | $808.08M | +15.9% | +$111.15M | ||
| 2003 | $696.93M | — | — |
- 2025$1.45B+33.4%
- 2024$1.09B-8.0%
- 2023$1.18B-19.6%
- 2022$1.47B+57.5%
- 2021$935.00M-10.8%
- 2020$1.05B+79.2%
- 2019$584.70M+30.2%
- 2018$449.20M+7.2%
- 2017$418.90M-63.2%
- 2016$1.14B-15.6%
- 2015$1.35B+374.9%
- 2014$284.10M-30.5%
- 2013$408.60M+16.8%
- 2012$349.97M-15.7%
- 2011$415.02M-42.0%
- 2010$715.11M+56.8%
- 2009$456.04M-28.7%
- 2008$639.72M+11.1%
- 2007$575.56M—
- 2005$518.13M-35.9%
- 2004$808.08M+15.9%
- 2003$696.93M—
Cash on Hand values are taken from Viatris's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's latest reported cash and short-term investments is $1.80B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Viatris (VTRS) reported cash and short-term investments of $1.45B – surged 33.4% year-over-year.
Over 2020–2025 (5 years), Viatris cash and short-term investments expanded at a +6.8% compound annual rate, with mixed annual results across the window.
Viatris cash and short-term investments peaked at $1.47B in 2022; the latest annual figure is $1.45B in 2025 (1.2% below peak).
2022 marks the peak cash and short-term investments at $1.47B, with the historical low of $284.10M recorded in 2014.
Viatris Cash on Hand by Year
Viatris Cash on Hand 2025: $1.45B
Viatris posted cash and short-term investments of $1.45B in 2025, surged 33.4% from 2024.
Viatris Cash on Hand 2024: $1.09B
In 2024, Viatris reported cash and short-term investments of $1.09B, declined 8.0% below 2023.
Viatris Cash on Hand 2023: $1.18B
Viatris cash and short-term investments in 2023 was $1.18B, declined 19.6% below 2022.
Viatris Cash on Hand 2022: $1.47B
2022's cash and short-term investments for Viatris came in at $1.47B, surged 57.5% from 2021. This figure represents the highest annual value in the available history.
Viatris Cash on Hand 2021: $935.00M
Viatris cash and short-term investments in 2021 was $935.00M.
See more financial history for Viatris (VTRS).
Sector peers by Cash on Hand
Healthcare peers of Viatris (VTRS), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation